ImmuCell Corporation
ICCCBiotechnology
$10.26−0.58%As of Oct 30vs prior close
- Market cap
- $93.2M
- P/E (TTM)
- 146.6×
- From 52W high
- −12.46%
- EPS (LTM)
- $0.07
- Revenue (LTM)
- $30.7M
- Net margin
- 2.57%
- Dividend yield
- 0.00%
Nomior Score
72
Steady ProfileTop 8% of the scored universe
Growth—
Quality74
Value63
Momentum78
Resilience54
Growth
+12.96%revenue a year over 8 fiscal years
YE17 $10.4MLTM $30.7M
Connections
Revenue to profitQ2 YE26
26% of revenue became net profit, up 18 pts on a year.
Who owns it
1fund